Singapore Medical Group (SMG)

Singapore Medical Group kept at 'buy' on strong FY18 results, CHAS investment
SINGAPORE (Feb 21): RHB Research is maintaining Singapore Medical Group (SMG) at “buy” on news that shareholder CHA Healthcare Singapore (CHAS) is raising its stake in the group. On Wednesday, SMG announced that CHAS and five existing shareholders have entered into an agreement to purchase a total of 83 million shares at 60.5 cents each or $50.2 million in total. Upon completion, CHA ...
SMG calls for trading halt pending announcement as share price climbs 4.4%
SINGAPORE (Feb 20): Singapore Medical Group (SMG) at noon on Wednesday called for a trading halt “pending [the] release of [an] announcement”. Within the first three hours of trading before it requested for the halt, SMG’s share price had climbed 4.4% to 47 cents. This comes hot on the heels of SMG’s results announcement last evening, when it reported a 52.1% jump in full-year ...
Singapore Medical Group reports 17.2% higher 4Q earnings of $2.9 mil on revenue growth
SINGAPORE (Feb 19): Singapore Medical Group (SMG) posted a 17.2% rise in 4Q18 earnings to $2.9 million from $2.5 million a year ago, driven by increased revenue contributions from the health and diagnostic & aesthetic business segments. Revenue for the latest quarter grew 18.1% to $22.2 million from $18.8 million in 4Q17. The health business segment’s kids clinics, which were acquired ...
Market valuations may be inexpensive but stay defensive: RHB
SINGAPORE (Jan 2): RHB Research prefers to stay selective and defensive amid growth uncertainties in 2019. The Straits Times Index (STI), down 12% in USD terms, could remain under pressure this year amid slowing GDP growth and an uncertain trade outlook due to China-US tensions. In a Wednesday report, analyst Shekhar Jaiswal says, “While 12.6x forward P/E and 4.2% dividend yield make the ...
Singapore Medical Group kept at ‘buy’ for capturing market share from competitors
SINGAPORE (May 16): RHB Research says Singapore Medical Group must be doing something right to capture market share in the private medical practice space from its competitors. In addition, SW1, the aesthetic and plastic surgery clinic that was acquired at the end of March, is already profitable and is expected to contribute positively to the group’s bottomline from 2Q18. RHB Research ...
Singapore Medical Group reports more than doubling of 1Q earnings to $3.4 mil on topline growth
SINGAPORE (May 15): Singapore Medical Group, the healthcare services provider with an expanding regional network, reported 1Q18 earnings more than doubled to $3.4 million from $1.4 million. SMG says following its transformation into one of the largest specialist practitioners dedicated towards women’s health and wellness, the group reported a 37% increase in revenue to $19.2 million for ...
Transforming healthcare into a business
SINGAPORE (Mar 23): Tony Tan, non-executive chairman of Singapore Medical Group (SMG) co-founded Parkway Holdings in 1979 and was its managing director until 2000. In 2002, he was appointed deputy chairman, a position he held until his retirement in 2005. While Tan ran Parkway, the group evolved from a property company into a major healthcare player in Singapore, beginning with its ...
Record FY17 for Singapore Medical Group with FY18 expected to be stronger
SINGAPORE (Mar 2): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 68 cents, as the group’s turnaround is further validated by organic and inorganic growth. This came on the back of the group announcing that its FY17 earnings surged 250.8% to a record $8.5 million from $2.42 million in FY16. See: Singapore Medical Group FY17 earnings surge ...
More acquisitions likely for Singapore Medical Group in 2018
SINGAPORE (Mar 1): UOB Kay Hian is maintaining its “buy” call on Singapore Medical Group (SMG) with a P/E-based target price of 83 cents, pegged to the peer average FY18 P/E ratio of 26.8 times. In a Thursday report, analyst Nicholas Leow highlights that the group’s 4Q17 results announced yesterday were in line with UOB’s estimates with FY17 earnings more than trebling to $8.5 mil due ...
Singapore Medical Group FY17 earnings surge 250.8% to $8.5 mil on higher revenue
SINGAPORE (Feb 28): Singapore Medical Group (SMG) announced that its FY17 earnings has increased by 250.8% to $8.50 million compared to $2.42 million in FY16. Revenue for the full year ended Dec 31 2017 came in at $68.0 million, 63.5% higher than $41.6 million last year. The increase was mainly due to an increase in revenue in the group’s health business segment mainly contributed by the ...